Verici Dx unveils new genetic test but shares fall
(Alliance News) - Verici Dx PLC on Monday announced the launch of TranscripTx, a genetic test designed for transplant patients, in the last quarter of the year. Read More
| Price | 0.225p on 24-09-2026 at 08:45:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.25p |
| Sell | 0.20p |
| Last Trade: | Buy 824.00 at 0.25p |
| Day's Volume: | 824 |
| Last Close: | 0.225p |
| Open: | 0.225p |
| ISIN: | GB00BM8HZD43 |
| Day's Range | 0.225p - 0.225p |
| 52wk Range: | 0.20p - 0.95p |
| Market Capitalisation: | £5.15m |
| VWAP: | 0.25p |
| Shares in Issue: | 2.29b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Verici Dx (VRCI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 824 | 0.25p | Ordinary |
08:31:08 - 24-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
16:01:17 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
15:59:43 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
15:58:40 - 23-Sep-26 |
| Buy* | 500,000 | 0.25p | Ordinary |
15:56:43 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
15:34:27 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
15:32:58 - 23-Sep-26 |
| Sell* | 154,285 | 0.20p | Ordinary |
10:38:34 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
09:32:38 - 23-Sep-26 |
| Buy* | 1 | 0.25p | Ordinary |
09:31:38 - 23-Sep-26 |
Verici Dx (VRCI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Sep 2026 7:00 am | RNS-R | Q4 launch of TranscripTx™ genetic test |
| 18th Sep 2026 11:15 am | RNS | Holding(s) in Company |
| 27th Aug 2026 9:37 am | RNS | Holding(s) in Company |
| 11th Aug 2026 7:00 am | RNS | Certified Service Provider agreement with Olink® |
| 4th Aug 2026 4:29 pm | RNS | Holding(s) in Company |
| 28th Jul 2026 2:20 pm | RNS | Result of AGM |
| 6th Jul 2026 7:00 am | RNS-R | Investor presentation |
| 1st Jul 2026 11:22 am | RNS | Holding(s) in Company |
| 29th Jun 2026 7:00 am | RNS | Final results for the year ended 31 December 2025 |
| 25th Jun 2026 4:08 pm | RNS | Holding(s) in Company |